Monday 28 February 2011

Isosorbide mononitraat Delphi




Isosorbide mononitraat Delphi may be available in the countries listed below.


Ingredient matches for Isosorbide mononitraat Delphi



Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Isosorbide mononitraat Delphi in the following countries:


  • Netherlands

International Drug Name Search

Saturday 26 February 2011

Nuheart




Nuheart may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Nuheart



Ivermectin

Ivermectin is reported as an ingredient of Nuheart in the following countries:


  • Australia

International Drug Name Search

Tamoxifen Sopharma




Tamoxifen Sopharma may be available in the countries listed below.


Ingredient matches for Tamoxifen Sopharma



Tamoxifen

Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tamoxifen Sopharma in the following countries:


  • Bulgaria

International Drug Name Search

Friday 25 February 2011

Spectrasone




Spectrasone may be available in the countries listed below.


Ingredient matches for Spectrasone



Erythromycin

Erythromycin estolate (a derivative of Erythromycin) is reported as an ingredient of Spectrasone in the following countries:


  • South Africa

International Drug Name Search

Wednesday 23 February 2011

Citanest Octapressin




Citanest Octapressin may be available in the countries listed below.


Ingredient matches for Citanest Octapressin



Felypressin

Felypressin is reported as an ingredient of Citanest Octapressin in the following countries:


  • Bahrain

  • Denmark

  • Egypt

  • Iraq

  • Japan

  • Jordan

  • Kuwait

  • Lebanon

  • Libya

  • Oman

  • Qatar

  • Saudi Arabia

  • Syria

  • United Arab Emirates

  • Yemen

Prilocaine

Prilocaine hydrochloride (a derivative of Prilocaine) is reported as an ingredient of Citanest Octapressin in the following countries:


  • Bahrain

  • Denmark

  • Egypt

  • Iraq

  • Japan

  • Jordan

  • Kuwait

  • Lebanon

  • Libya

  • Oman

  • Qatar

  • Saudi Arabia

  • Syria

  • United Arab Emirates

  • Yemen

International Drug Name Search

Tuesday 22 February 2011

Lipistat




Lipistat may be available in the countries listed below.


Ingredient matches for Lipistat



Atorvastatin

Atorvastatin is reported as an ingredient of Lipistat in the following countries:


  • Myanmar

International Drug Name Search

Saturday 19 February 2011

D-Tab


Generic Name: guaifenesin and phenylephrine (gwye FEN e sin and FEN il EFF rin)

Brand Names: Aldex G, Aquatab D, Crantex, D-Phen 1000, D-Tab, Deconex, Deconsal II, Deconsal Pediatric, Despec, Donatussin Drops, Duomax, Duraphen 1000, Duraphen II, Duratuss, Dynex LA, ExeTuss, Extendryl G, Fenesin PE IR, Genexa LA, Gentex LA, Gilphex TR, Guaiphen-D 1200, Guaiphen-D 600, Guaiphen-PD, Guiadex PD, Guiatex PE, J-Max, Liquibid D-R, Liquibid-D, Liquibid-PD, Lusonex, Maxiphen, Medent-PE, MontePhen, Mucinex Children's Cold, Mucus Relief Sinus, Mydex, Nariz, Nasex, Nescon-PD, Nexphen PD, Norel EX, PE-Guai, Pendex, Prolex D, Refenesen PE, Reluri, Rescon-GG, Respa-PE, Robitussin Head & Chest Congestion, Simuc, Simuc-GP, Sina-12X, Sinupan, SINUvent PE, Sitrex PD, Sudafed PE Non-Drying Sinus, Sudex, Triaminic Chest & Nasal Congestion, Visonex, Wellbid-D, Xedec, Xedec II, Xpect-PE, Zotex GPX


What is D-Tab (guaifenesin and phenylephrine)?

There are many brands and forms of guaifenesin and phenylephrine available and not all brands are listed on this leaflet.


Guaifenesin is an expectorant. It helps loosen congestion in your chest and throat, making it easier to cough out through your mouth.


Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of guaifenesin and phenylephrine is used to treat stuffy nose and sinus congestion, and to reduce chest congestion caused by the common cold or flu.


Guaifenesin and phenylephrine may also be used for purposes not listed in this medication guide.


What is the most important information I should know about D-Tab (guaifenesin and phenylephrine)?


There are many brands and forms of guaifenesin and phenylephrine available and not all brands are listed on this leaflet.


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Ask a doctor or pharmacist before using any other cough, cold, or allergy medicine. Guaifenesin and phenylephrine are contained in many combination medicines. Taking certain products together can cause you to get too much of a certain drug. Check the label to see if a medicine contains guaifenesin or phenylephrine.

What should I discuss with my healthcare provider before taking D-Tab (guaifenesin and phenylephrine)?


You should not use this medication if you are allergic to guaifenesin or phenylephrine, or to other decongestants, diet pills, stimulants, or ADHD medications. Do not use guaifenesin and phenylephrine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. Serious, life threatening side effects can occur if you use guaifenesin and phenylephrine before the MAO inhibitor has cleared from your body.

Ask a doctor or pharmacist if it is safe for you to take this medication if you have:



  • heart disease or high blood pressure;




  • diabetes;




  • circulation problems;




  • glaucoma;




  • overactive thyroid; or




  • enlarged prostate or problems with urination.




It is not known if this medication may be harmful to an unborn baby. Do not use this medication without your doctor's advice if you are pregnant. This medication passes into breast milk and could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Artificially-sweetened liquid forms of cold medicine may contain phenylalanine. This would be important to know if you have phenylketonuria (PKU). Check the ingredients and warnings on the medication label if you are concerned about phenylalanine.


How should I take D-Tab (guaifenesin and phenylephrine)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Cold medicine is usually taken only for a short time until your symptoms clear up.


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving cough or cold medicine to a child. Death can occur from the misuse of cough or cold medicine in very young children.

Measure the liquid form of this medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


Do not crush, chew, break, or open an extended-release tablet or capsule. Swallow it whole. Breaking or opening the pill may cause too much of the drug to be released at one time. Take guaifenesin and phenylephrine with food if it upsets your stomach. Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache, cough, or skin rash. Drink extra fluids to help loosen the congestion and lubricate your throat while you are taking this medication. Store at room temperature away from moisture and heat.

What happens if I miss a dose?


Since cough or cold medicine is taken as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include nausea, vomiting, numbness or tingly feeling, dizziness, and feeling restless or nervous.


What should I avoid while taking D-Tab (guaifenesin and phenylephrine)?


This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Drinking alcohol can increase certain side effects of guaifenesin and phenylephrine. Ask a doctor or pharmacist before using any other cough, cold, or allergy medicine. Guaifenesin and phenylephrine are contained in many combination medicines. Taking certain products together can cause you to get too much of a certain drug. Check the label to see if a medicine contains guaifenesin or phenylephrine.

Avoid taking this medication with diet pills, caffeine pills, or other stimulants (such as ADHD medications) without your doctor's advice. Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.


D-Tab (guaifenesin and phenylephrine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have any of these serious side effects:

  • fast, pounding, or uneven heartbeat;




  • severe dizziness, anxiety, restless feeling, or nervousness;




  • easy bruising or bleeding, unusual weakness, fever, chills, body aches, flu symptoms;




  • dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, shortness of breath, uneven heartbeats, seizure); or




  • nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).



Less serious side effects may include:



  • vomiting, upset stomach;




  • warmth, tingling, or redness under your skin;




  • feeling excited or restless (especially in children);




  • sleep problems (insomnia);




  • skin rash or itching;




  • headache; or




  • dizziness.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect D-Tab (guaifenesin and phenylephrine)?


Ask a doctor or pharmacist if it is safe for you to take guaifenesin and phenylephrine if you are also using any of the following drugs:



  • medicines to treat high blood pressure;




  • a beta-blocker such as atenolol (Tenormin, Tenoretic), carvedilol (Coreg), labetalol (Normodyne, Trandate), metoprolol (Dutoprol, Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), and others; or




  • an antidepressant such as amitriptyline (Elavil, Vanatrip, Limbitrol), doxepin (Sinequan, Silenor), desipramine (Norpramin), imipramine (Janimine, Tofranil), nortriptyline (Pamelor), and others.



This list is not complete and other drugs may interact with guaifenesin and phenylephrine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More D-Tab resources


  • D-Tab Side Effects (in more detail)
  • D-Tab Use in Pregnancy & Breastfeeding
  • D-Tab Drug Interactions
  • D-Tab Support Group
  • 0 Reviews for D-Tab - Add your own review/rating


  • Crantex Prescribing Information (FDA)

  • Despec Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Entex LA Sustained-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

  • Gentex LA Sustained-Release Tablets (12 Hour) MedFacts Consumer Leaflet (Wolters Kluwer)

  • Guiatex PE Prescribing Information (FDA)

  • Lusonex Controlled-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rescon-GG Liquid MedFacts Consumer Leaflet (Wolters Kluwer)

  • Sina-12X Suspension MedFacts Consumer Leaflet (Wolters Kluwer)



Compare D-Tab with other medications


  • Cough and Nasal Congestion
  • Sinus Symptoms


Where can I get more information?


  • Your pharmacist can provide more information about guaifenesin and phenylephrine.

See also: D-Tab side effects (in more detail)


Friday 18 February 2011

Eta Biocortilen




Eta Biocortilen may be available in the countries listed below.


Ingredient matches for Eta Biocortilen



Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Eta Biocortilen in the following countries:


  • Italy

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Eta Biocortilen in the following countries:


  • Italy

International Drug Name Search

Tuesday 15 February 2011

Paroxetina Ranbaxy




Paroxetina Ranbaxy may be available in the countries listed below.


Ingredient matches for Paroxetina Ranbaxy



Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetina Ranbaxy in the following countries:


  • Italy

  • Spain

International Drug Name Search

Monday 14 February 2011

Ucetam




Ucetam may be available in the countries listed below.


Ingredient matches for Ucetam



Piracetam

Piracetam is reported as an ingredient of Ucetam in the following countries:


  • Myanmar

International Drug Name Search

Thursday 10 February 2011

Pannogel




Pannogel may be available in the countries listed below.


Ingredient matches for Pannogel



Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Pannogel in the following countries:


  • France

International Drug Name Search

Tuesday 8 February 2011

Némaprol




Némaprol may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Némaprol



Amprolium

Amprolium hydrochloride (a derivative of Amprolium) is reported as an ingredient of Némaprol in the following countries:


  • France

International Drug Name Search

Thursday 3 February 2011

Nicodel LA




Nicodel LA may be available in the countries listed below.


Ingredient matches for Nicodel LA



Nicardipine

Nicardipine hydrochloride (a derivative of Nicardipine) is reported as an ingredient of Nicodel LA in the following countries:


  • Japan

International Drug Name Search

Wednesday 2 February 2011

Blood Stop





Dosage Form: FOR ANIMAL USE ONLY
Blood Stop POWDER

INDICATIONS


INDICATIONS: For use as an aid in controlling minor bleeding from superficial cuts and wounds and after dehorning.



Blood Stop Dosage and Administration


DOSAGE AND ADMINISTRATION: Apply powder freely to bleeding surface.  Repeat as needed. Bandage if necessary.



Contraindications


CONTRAINDICATIONS: In case of deep or puncture wounds or serious burns, consult veterinarian. If redness, irritation, or swelling persists or increases, discontinue use and consult veterinarian.


B-1101-07               Rev. 1-96





CONTENTS


CONTENTS: Ferrous Sulfate • 7H2O 84.0%, Ammonium Alum 5%, Chloroxylenol 1%, Tannic Acid 1%, In a free-flowing absorbent base. Not sterilized.


For external use only.



Store at controlled room temperature between 15o-30oC (59o-86oF)


Keep container tightly closed.


TAKE TIME OBSERVE LABEL DIRECTIONS


Lot No.


Exp. Date









Blood Stop 
iron  powder










Product Information
Product TypeOTC ANIMAL DRUGNDC Product Code (Source)58005-730
Route of AdministrationTOPICALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
FERROUS SULFATE (IRON)FERROUS SULFATE381.4 g  in 454 g





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
158005-730-07454 g In 1 JARNone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other08/11/1995


Labeler - Sparhawk Laboratories, Inc. (958829558)
Revised: 01/2010Sparhawk Laboratories, Inc.



Mazindol




In the US, Mazindol (mazindol systemic) is a member of the following drug classes: anorexiants, CNS stimulants and is used to treat Obesity and Weight Loss.

US matches:

  • Mazindol

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A08AA05

CAS registry number (Chemical Abstracts Service)

0022232-71-9

Chemical Formula

C16-H13-Cl-N2-O

Molecular Weight

284

Therapeutic Categories

Central stimulant

Anorexic agent

Chemical Names

(RS)-5-(4-Chlorphenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol (IUPAC)

5-(p-Chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol (WHO)

Foreign Names

  • Mazindolum (Latin)
  • Mazindol (German)
  • Mazindol (French)
  • Mazindol (Spanish)

Generic Names

  • Mazindol (OS: BAN, DCF, USAN)
  • Mazindolo (OS: DCIT)
  • 42-548 (IS: Sandoz)
  • AN 488 (IS)
  • Mazindol (PH: USP 32)

Brand Names

  • Afilan
    Quesada, Argentina


  • Diestet
    Darier, Mexico; Pfizer, Costa Rica; Pfizer, Guatemala; Pfizer, Honduras; Pfizer, Panama; Pfizer, Peru; Pfizer, El Salvador


  • Dimagrir
    Gador, Argentina


  • Ifa Lose
    Investigacion Farmaceutica, Mexico


  • Mz1
    Medix, Costa Rica; Medix, Dominican Republic; Medix, Guatemala; Medix, Honduras; Medix, Mexico; Medix, Panama; Medix, El Salvador


  • Qualizindol
    Quality, Hong Kong


  • Rezin
    Raam, Mexico


  • Samonter
    Sanitas, Argentina


  • Sanorex
    Novartis, Japan


  • Solucaps
    Medix, Costa Rica; Medix, Dominican Republic; Medix, Guatemala; Medix, Honduras; Medix, Mexico; Medix, Panama; Medix, El Salvador


  • Teronac
    Novartis, Ghana; Novartis, Indonesia; Novartis, Israel; Novartis, Kenya; Novartis, Libya; Novartis, Nigeria; Novartis, Sudan; Novartis, Singapore; Novartis, Tanzania; Novartis, Zimbabwe

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 1 February 2011

Moxonidine Sandoz




Moxonidine Sandoz may be available in the countries listed below.


Ingredient matches for Moxonidine Sandoz



Moxonidine

Moxonidine is reported as an ingredient of Moxonidine Sandoz in the following countries:


  • Belgium

  • Netherlands

International Drug Name Search